Genetix Biotech Asia Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 13-01-2025
- Paid Up Capital ₹ 10.65 Cr
as on 13-01-2025
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 93.69 Cr
as on 13-01-2025
- Satisfied Charges ₹ 64.30 Cr
as on 13-01-2025
- Revenue -53.23%
(FY 2023)
- Profit -74.30%
(FY 2023)
- Ebitda -72.89%
(FY 2023)
- Net Worth 10.30%
(FY 2023)
- Total Assets 1.60%
(FY 2023)
About Genetix Biotech Asia
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.65 Cr.
The company currently has active open charges totaling ₹93.69 Cr. The company has closed loans amounting to ₹64.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Genetix Biotech Asia Limited India are Sunil Kumar as COMPANY SECRETARY and Sandeep Aggarwal as Cfo. Rakesh Dubey, Arun Prakash, Raminder Kaur, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24239DL2001PLC112768
- Company No.
112768
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Genetix Biotech Asia Limited offer?
Genetix Biotech Asia Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Face Mask & Medical PPE Kits, Cleanroom Clothing, PCR Machine, Bulk Bags & Sacks, Garbage and Waste Bags, Chemical Reagents & Catalysts, Organic Acid, Autoclaves, Sterilizers & Incubators.
Who are the key members and board of directors at Genetix Biotech Asia?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Prakash  | Managing Director | 10-Oct-2001 | Current |
| Sunil Kumar | Company Secretary | 11-Sep-2024 | Current |
| Sandeep Aggarwal | CFO | 08-Aug-2024 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raminder Kaur | Whole-Time Director | 10-Oct-2001 | Current |
| Rakesh Dubey | Additional Director | 18-Nov-2024 | Current |
| Vinod Wuthoo | Additional Director | 18-Nov-2024 | Current |
| Poonam Deep | Director | 16-May-2020 | Current |
| Samuel Farrimond | Additional Director | 11-Dec-2024 | Current |
Financial Performance of Genetix Biotech Asia.
Genetix Biotech Asia Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.23% decrease. The company also saw a substantial fall in profitability, with a 74.3% decrease in profit. The company's net worth Soared by an impressive increase of 10.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genetix Biotech Asia?
In 2023, Genetix Biotech Asia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Studio Diagnostics Private LimitedActive 4 years 1 dayArun Prakash, Raminder Kaur and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Aug 2024 | ₹8.00 M | Open |
Others Creation Date: 24 Jan 2024 | ₹11.06 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Jan 2024 | ₹0.46 M | Open |
How Many Employees Work at Genetix Biotech Asia?
Genetix Biotech Asia has a workforce of 127 employees as of Jan 13, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genetix Biotech Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetix Biotech Asia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
